Scarica l'app Stockscreener
27.32
3.96%
1.0401
Dopo l'orario di chiusura:
27.32
Precedente Chiudi:
$26.28
Aprire:
$26.47
Volume 24 ore:
6,547
Relative Volume:
1.87
Capitalizzazione di mercato:
$2.55B
Reddito:
$80.00M
Utile/perdita netta:
$-172.98M
Rapporto P/E:
-14.07
EPS:
-1.9419
Flusso di cassa netto:
$164.80M
1 W Prestazione:
+28.29%
1M Prestazione:
+15.47%
6M Prestazione:
-31.32%
1 anno Prestazione:
+18.78%
Intervallo 1D:
$26.47
$27.33
Intervallo di 1 settimana:
$22.89
$27.33
Portata 52W:
$17.55
$48.45
Ascentage Pharma Group International Adr Stock (AAPG) Company Profile
Nome
Ascentage Pharma Group International Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare AAPG vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AAPG
Ascentage Pharma Group International Adr
|
27.32 | 2.55B | 80.00M | -172.98M | 164.80M | -1.9419 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Ascentage Pharma Group International Adr Stock (AAPG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-12 | Ripresa | BTIG Research | Buy |
| 2026-01-13 | Iniziato | Rodman & Renshaw | Buy |
| 2025-12-04 | Iniziato | Oppenheimer | Outperform |
| 2025-11-24 | Iniziato | Truist | Buy |
| 2025-11-10 | Iniziato | BTIG Research | Buy |
| 2025-11-05 | Iniziato | Piper Sandler | Overweight |
| 2025-03-27 | Iniziato | JP Morgan | Overweight |
Mostra tutto
Ascentage Pharma Group International Adr Borsa (AAPG) Ultime notizie
Ascentage Pharma Group International (NASDAQ:AAPG) Trading Up 12%Should You Buy? - MarketBeat
Why nCino Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - Sahm
Ascentage Pharma Group International (NASDAQ:AAPG) Sees Large Volume IncreaseHere's Why - MarketBeat
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap UpHere's What Happened - MarketBeat
Ascentage Pharma Group InternationalUnsponsored ADR (NASDAQ:AAPG) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Truist Financial Remains a Buy on Ascentage Pharma Group International Unsponsored ADR (AAPG) - The Globe and Mail
BTIG Remains a Buy on Ascentage Pharma Group International Unsponsored ADR (AAPG) - The Globe and Mail
Earnings Scheduled For March 25, 2026 - Sahm
Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates - GlobeNewswire Inc.
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Up 20.3%Should You Buy? - marketbeat.com
Short Interest in Ascentage Pharma Group InternationalUnsponsored ADR (NASDAQ:AAPG) Increases By 546.9% - MarketBeat
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap DownTime to Sell? - MarketBeat
Ascentage Pharma Group International (NASDAQ:AAPG) Stock Price Down 7.7%Here's Why - MarketBeat
Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026 - Sahm
Ascentage Pharma Sets March 25 Board Meeting on 2025 Results and Potential Final Dividend - TipRanks
Ascentage Pharma Sets March 25, 2026 Date to Unveil 2025 Unaudited Results and Business Update - The Globe and Mail
Analysts Are Bullish on Top Healthcare Stocks: Abivax SA Sponsored ADR (ABVX), Irhythm Technologies (IRTC) - The Globe and Mail
Ascentage Pharma Ramps Up Investor Outreach With Three U.S. Conferences - TipRanks
Rodman & Renshaw Initiates Ascentage Pharma Group International (AAPG) with Buy Rating, $48 Target - Finviz
Ascentage Pharma to Present at Guggenheim Biotech Summit as Late-Stage Oncology Pipeline Expands - The Globe and Mail
Ascentage Pharma Wins China IND Clearance for Next-Gen BTK Degrader APG-3288 - TipRanks
Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288 - Sahm
Analysts Have Conflicting Sentiments on These Healthcare Companies: Regeneron (REGN), Resmed (RMD) and Sanofi (OtherSNYNF) - The Globe and Mail
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) Sees Significant Increase in Short Interest - Defense World
Analysts Are Bullish on These Healthcare Stocks: Palvella Therapeutics (PVLA), Nurix Therapeutics (NRIX) - The Globe and Mail
Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) Short Interest Update - Defense World
Ascentage Pharma Details 2026 Global Innovation Strategy at J.P. Morgan Healthcare Conference - TipRanks
Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference - markets.businessinsider.com
Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Regeneron (REGN) and Progyny (PGNY) - The Globe and Mail
LENZ Therapeutics (LENZ) Receives a Buy from Piper Sandler - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: BeOne Medicines (ONC) and Vertex Pharmaceuticals (VRTX) - The Globe and Mail
Ascentage Pharma Group International Adr Azioni (AAPG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):